Joe's Petition + All My Links:
https://linktr.ee/manonthemounjaro

Dave discussed the latest update in the OFA vs FDA compound tirzepatide battle, as well as this weeks news in obesity medicine.

Find our substack and all promotional links here:
https://linktr.ee/manonthemounjaro

CVS announces major partnership with Novo Nordisk as Lilly announces Q! 2025 earnings. Dave covers it all in today's breakdown.

Join the Substack: https://substack.com/@onthepen

WAYS TO SUPPORT MY WORK ⬇️

💊 OVER THE COUNTER ORAL PEPTIDE SUPPLIMENTS:
BPC-157 // Can’t Weight // TB4-FRAG // KPV
Sign up here and use code “OTP10” to save 10%
https://integrativepeptides.com/OTP

WHY I TRUST INTEGRATIVE PEPTIDES:
🇺🇸 Made in the USA
📋 CGMP Compliant (FDA oversight of their products)
🧑‍⚕️Trusted and Sold By Doctors and Clinics all over the USA

📕 GET MY BOOK!
Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
https://amzn.to/4gAXrz4

SOCIALS:
📸 : https://www.instagram.com/onthepen.official/profilecard/?igsh=dTRhY3JkYWo1bTIx
🇨🇳: https://www.tiktok.com/@manonthemounjaro?_t=ZP-8sr5PrUuPQl&_r=1
👾: https://discord.gg/ZHeUh7WV
📺: https://youtube.com/@ManOnTheMounjaro?feature=shared
❌: https://x.com/manonthepen?s=21
💻: https://www.onthepen.com

https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com.